THE INTERSTITIAL LUNG DISEASE MULTIDISCIPLINARY MEETING POSITION STATEMENT OCTOBER 2017 On behalf of Lung Foundation Australia and the Thoracic Society of Australia and New Zealand JYOTIKA D. PRASAD, 1,2,3 ANNABELLE MAHAR, 4 JANE BLEASEL, 5,6 SAMANTHA J. ELLIS, 7 DANIEL C. CHAMBERS, 8,9 FIONA LAKE, 10,11 PETER M.A. HOPKINS, 8,9 TAMERA J. CORTE, 12,13 HEATHER ALLAN 14 AND IAN N. GLASPOLE 1,3 1 Department of Respiratory and Sleep Medicine, Alfred Hospital, Melbourne, VIC; 2 Department of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Melbourne, VIC; 3 Central Clinical School, Monash University, Melbourne, VIC; 4 Pathology Department, Royal Prince Alfred Hospital, Sydney, NSW; 5 Rheumatology Department, Royal Prince Alfred Hospital, Sydney, NSW; 6 Sydney Medical Program, University of Sydney, Sydney, NSW; 7 Radiology Department, Alfred Hospital, Melbourne, VIC; 8 School of Medicine, The University of Queensland, Brisbane, QLD; 9 , Queensland Lung Transplant Service, Brisbane, QLD; 10 Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA; 11 School of Medicine and Pharmacy, University of Western Australia, Perth, WA; 12 Respiratory Department, Royal Prince Alfred Hospital, Sydney, NSW; 13 Central Clinical School, University of Sydney, Sydney, NSW; 14 , Lung Foundation Australia, Brisbane, QLD, Australia *This document has been peer reviewed by independent experts and subsequently endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) Board on 8 August 2017. http://onlinelibrary.wiley.com/doi/10.1111/resp.13163/full FROM THE THORACIC SOCIETY OF AUSTRALIA AND NEW ZEALAND AND THE LUNG FOUNDATION AUSTRALIA*